Phospholipid fatty acid composition (PLFA)

Phospholipid fatty acid composition refers to the specific types and proportions of fatty acids (saturated, monounsaturated, and polyunsaturated) that constitute the hydrophobic tails of phospholipids within biological membranes. This composition is a critical determinant of membrane fluidity, thickness, and the organization of lipid rafts, which in turn influences the function of membrane-bound receptors and ion channels (Source: PubMed, PMID: 28414328). It is not a single protein target but rather a physiological state or biomarker that reflects dietary intake and metabolic health. Changes in phospholipid fatty acid composition are strongly linked to various chronic conditions; for instance, a high proportion of saturated fats is associated with insulin resistance, while an increase in omega-3 polyunsaturated fatty acids is linked to reduced cardiovascular risk and anti-inflammatory effects (Source: NIH, StatPearls). Therapeutic intervention typically involves dietary supplementation or pharmaceutical-grade fatty acids (e.g., Icosapent ethyl) that integrate into the phospholipid bilayer to modulate inflammatory signaling and lipid metabolism (Source: PubChem). While it is often measured as a biomarker to assess disease risk, it is considered a 'systemic' or 'structural' target rather than a discrete molecular receptor or enzyme.

Other names

Membrane fatty acid profilePhospholipid fatty acid profileCellular lipid compositionMembrane lipidome

Modification of the lipid bilayer composition via direct incorporation of exogenous fatty acids into phospholipids, which displaces pro-inflammatory fatty acids like arachidonic acid and alters membrane-bound protein activity.